HOKT3
As of the edition of 20 October 2026, HOKT3 is a drug: stopped in 2004; acts on CD3E.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Stopped, 2004
- Kind
- Unknown
- Registered trials
- 1, 1 stopped early
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| CD3E | T-cell surface glycoprotein CD3 epsilon chain | P07766 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 3 | 1 | 0 | 0 | 1 |
| All trials | 1 |